Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos Medical Inc.’s Mild(R)
7/19/2010 11:05:48 AM
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS). Consistent with the positive six-week study results released in March and May, the new MiDAS I data demonstrate that mild patients continued to experience statistically significant improvement in pain, physical function and mobility 12 weeks following treatment. The study’s medical monitors also concluded that mild is safe, with no reports of major adverse events related to the procedure or devices.